Proprio: Seattle AI Profile — Product, Footprint & Verified Record

Modern Seattle computational biology and life-sciences research laboratory overlooking Pacific Northwest evergreens

About Will

I run Tygart Media, an AI-first agency that gets businesses cited and recommended by AI assistants — and I write about what we do, including what breaks.

Connect on LinkedIn →
Washington AI Companies Census · Verified Record (November 19, 2026)
Sourced Baseline: As of November 19, 2026, Proprio operates actively from its Seattle headquarters as a clinical-stage and commercial surgical navigation company spun out of the University of Washington. Its Paradigm platform combines light-field imaging, computer vision, and surgical AI models to guide spine procedures without repeated intraoperative radiation, backed by $75M–$84M in reported funding and a 50-person team listed on the Fall 2026 GeekWire 200.
PROFILE BRIEF · HOUSE PDF & MARKDOWN TWIN
Proprio — Seattle AI Profile
Download the formatted 2-page profile brief (PDF) or open the single-source Markdown twin for Proprio. Every claim below links to its verified primary source.

What Proprio Builds

Proprio develops Paradigm, an FDA-cleared, radiation-free surgical navigation and data intelligence system detailed on the Proprio website. Paradigm integrates light-field imaging, multi-camera computer vision, advanced sensors, and an AI foundation model built for surgery to continuously track anatomy at the segmental level in real time.

Instead of relying on repeated intraoperative CT scans or X-ray fluoroscopy to verify instrument and bone positions, Paradigm renders dynamic 3D surgical models and provides on-demand intraoperative measurements of spinal alignment, disc height, and segmental angles. As covered by GeekWire in 2023 and April 2025, the system aims to cut radiation exposure and workflow interruptions in complex spine and neurosurgery operating rooms.

Beyond real-time guidance, Paradigm passively records structured intraoperative data during every procedure. Proprio positions this dataset—which its website states draws contributions from hundreds of surgeons—to support institutional learning, clinical training, and surgical safety programs.

  • Radiation-free 3D navigation: Combines light-field imaging, computer vision, and sensor fusion to render dynamic 3D surgical views without repeated CT or X-ray scans.
  • Real-time intraoperative metrics: Delivers on-demand measurements of spinal alignment, disc height, and segmental angles while tracking anatomy continuously.
  • Surgical AI foundation model: Uses an AI foundation model informed by hundreds of contributing surgeons, paired with passive intraoperative data capture.
  • Iterative FDA 510(k) milestones: Received its second major FDA 510(k) clearance in April 2025 for real-time measurements and announces a third major 510(k) clearance on its live site for 3D dynamic segmental viewing.
Proprio — Verified Washington AI Snapshot
Verified profile snapshot for Proprio (Seattle, WA) as of November 19, 2026.
FieldVerified Record (As of Nov 19, 2026)
CompanyProprio
Official Websitepropriovision.com
Washington HQ111 W John St, Suite 308, Seattle, WA 98119
Other WA FootprintUniversity of Washington spinout; active clinical use and validation at UW Medicine / Harborview Medical Center
Founded2016 (GeekWire 200, Fall 2026)
Founders / LeadershipGabriel Jones (Co-Founder & CEO); Dr. Samuel R. Browd (Co-Founder & CMO); Dr. Joshua R. Smith (Co-Founder & CTO)
StageSeries B / Growth
Announced Funding$75M–$84M (GeekWire reported $84M to date in April 2025, including $43M Series B in 2023; Tracxn/PitchBook report $75M–$82M)
Team Size50 (GeekWire 200, Fall 2026)
Primary Ecosystem TiesUW spinout; UW Medicine / Harborview clinical deployment; Fall 2026 GeekWire 200; 2024 GeekWire Awards honoree; Seattle-area investors including Alan Frazier / East Seattle Partners

Washington Footprint and Leadership

Proprio is headquartered in Seattle's Lower Queen Anne / Uptown area at 111 W John St, Suite 308, Seattle, WA 98119, as listed in the footer of propriovision.com. The company spun out of the University of Washington in 2016 and retains deep academic and clinical roots across Seattle's medical research corridor.

The founding leadership team profiled on Proprio's About page combines startup execution with UW medical and robotics faculty: Co-Founder and CEO Gabriel Jones leads the business alongside Co-Founder and Chief Medical Officer Dr. Samuel R. Browd, a pediatric neurosurgeon and UW faculty physician, and Co-Founder and Chief Technology Officer Dr. Joshua R. Smith, a UW professor specializing in robotics and sensor systems.

Clinical validation has remained anchored locally at UW Medicine and Harborview Medical Center in Seattle. On the Fall 2026 GeekWire 200, Proprio is listed with 50 employees.

Get The Signal

What we actually ran, what it measured, and what it means for a restoration shop — every week, including the flops.

Subscription Form

  • Seattle headquarters: Located at 111 W John St, Suite 308, Seattle, WA 98119, with 50 employees listed in Fall 2026.
  • UW academic spinout: Co-founded in 2016 by CEO Gabriel Jones alongside UW faculty Dr. Samuel R. Browd (neurosurgery) and Dr. Joshua R. Smith (robotics and sensors).
  • Local clinical validation: Actively deployed at UW Medicine / Harborview Medical Center, with UW spine surgeon Dr. Rick Bransford featured on the company's homepage.
  • Regional recognition: Listed on the Fall 2026 GeekWire 200 and recognized among finalists and honorees at the 2024 GeekWire Awards.
Aerial view of the Greater Seattle and Bellevue Lake Washington technology corridor with Mount Rainier on the horizon
Washington AI ecosystem context: Aerial view of the Greater Seattle and Bellevue Lake Washington technology corridor with Mount Rainier on the horizon.

Products, Users, and Public Traction

Proprio builds for spine and neurosurgeons, academic hospitals, ambulatory surgery centers (ASCs), and integrated health systems. In April 2025, GeekWire reported Proprio's second major FDA clearance for capturing real-time intraoperative measurements, noting active clinical deployments at UW Medicine and Duke Health.

By November 2026, the Proprio homepage announced a third major FDA 510(k) clearance enabling 3D, dynamic, segmental anatomical viewing. Named surgeon endorsements on the site include Dr. Rick Bransford, Dr. Sig Berven, and Dr. Brett Rocos, alongside references to the HSG Research Collaboration.

On the commercial and technology partner side, Proprio has partnered with LifeHealthcare for Southeast Asia distribution and works with Intel and HTC as technology partners. In 2025, the company also announced that Paradigm received a Fast Company 2025 World Changing Ideas Award.

  • Academic health system adoption: Clinical deployments reported at UW Medicine / Harborview Medical Center and Duke Health.
  • Three FDA 510(k) clearances: Progressed from initial surgical navigation clearance to real-time intraoperative measurements (April 2025) and dynamic 3D segmental viewing announced on its live homepage.
  • Distribution & hardware partners: Partnered with LifeHealthcare for Southeast Asia distribution and aligned with Intel and HTC on compute and optical/XR hardware.
  • External awards & clinical research: Honored with a Fast Company 2025 World Changing Ideas Award and linked to the HSG Research Collaboration.

Funding, Stage, and Place in Washington's AI Landscape

Proprio is a Series B / Growth company with $75M–$84M in total reported funding. In April 2025, GeekWire reported that Proprio had raised $84 million to date, following a $43 million Series B round in 2023 and an earlier $23 million Series A, while private-market trackers Tracxn and PitchBook record totals in the $75M–$82M range.

Its investor syndicate spans deep-tech venture firms, corporate strategic backers, and Seattle life-science capital: DCVC (Data Collective), BOLD Capital Partners, Cota Capital, Intel Capital, HTC, Alan Frazier / East Seattle Partners, Hexagon VC, and Recode Health Ventures.

Within Washington's broader AI cluster, Proprio sits at the intersection of University of Washington computer vision research, regulated medical devices, and physical-world sensor AI. Alongside Seattle-area clinical and telerobotic peers, it demonstrates how local academic spinouts have paired regulatory clearances with hospital partnerships to build durable medical hardware-software platforms.

  • Funding range preserved: Total disclosed capital spans $75M–$84M ($84M reported by GeekWire in April 2025; $75M–$82M in Tracxn/PitchBook).
  • Major milestones: Raised a $43M Series B in 2023 shortly after initial FDA clearance, building on an earlier $23M round.
  • Deep-tech & local backers: Investors include DCVC, BOLD Capital Partners, Cota Capital, Intel Capital, HTC, Hexagon VC, Recode Health Ventures, and Seattle's Alan Frazier / East Seattle Partners.
  • Ecosystem role: Anchor example of UW robotics and medical faculty commercializing regulated computer-vision AI inside Seattle's hospital network.

Related Washington AI Profiles & Tygart Media Context

Verified Primary Sources

Get The Signal

What we actually ran, what it measured, and what it means for a restoration shop — every week, including the flops.

Subscription Form

Track the AI tools you actually use
Vendor-neutral prices & limits for ChatGPT, Claude, Gemini, Perplexity and more — tracked in AI Stack Watch.
See the live AI tracker →or set up your alerts

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *